As of Jun 29
| 0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 11.25, with a high estimate of 13.00 and a low estimate of 6.50. The median estimate represents a +29.76% increase from the last price of 8.67.
The current consensus among 7 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.